Nebulizers Market - Medical Devices Pipeline Assessment 2019


Report ID : RNR-264453 Category : Medical Devices Published Date : Apr-2019
Publisher : GlobalData Pages : 48 Format : PDF

Avail 15% Discount, Use RNR15 Coupon Code.
T&C*

Nebulizers are the devices which help in direct delivery of medicine in case of respiratory disorders. It turns liquid medicine into mist (aerosol) to treat asthma, COPD, cystic fibrosis and other respiratory disorders. Medical Devices sector report, “Nebulizers - Medical Devices Pipeline Assessment, 2019" provides comprehensive information about the Nebulizers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.


The Nebulizers Pipeline Assessment report provides key information and data related to:

Extensive coverage of the Nebulizers Market under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Nebulizers pipeline products.

Review of Recent Developments in the segment / industry

The Nebulizers market Pipeline Assessment report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Nebulizers Market under development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

This report is prepared using data sourced from in-house databases, secondary and primary research by team of industry experts.



Scope
– Extensive coverage of the Nebulizers Market under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Nebulizers Market and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry


Reasons to buy
The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of Nebulizers Market under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date


Companies mentioned
Ablynx NV

Aeon Research & Technology

AFT Pharmaceuticals Ltd

Aura Medical

Baby's Breath Ltd.

Creare LLC

DesignWise Medical Inc (Inactive)

Marquette University

Parion Sciences Inc

SolAeroMed Inc

Stirling Pharma Inc

University of California San Diego

University of Texas Medical Branch at Galveston

Verona Pharma Plc

Vincent Medical Holdings Ltd
Table of Contents
1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Nebulizers Overview 6

3 Products under Development 7

3.1 Nebulizers - Pipeline Products by Stage of Development 7

3.2 Nebulizers - Pipeline Products by Segment 8

3.3 Nebulizers - Pipeline Products by Territory 9

3.4 Nebulizers - Pipeline Products by Regulatory Path 10

3.5 Nebulizers - Pipeline Products by Estimated Approval Date 11

3.6 Nebulizers - Ongoing Clinical Trials 12

4 Nebulizers - Pipeline Products under Development by Companies 13

4.1 Nebulizers Companies - Pipeline Products by Stage of Development 13

4.2 Nebulizers - Pipeline Products by Stage of Development 14

5 Nebulizers Companies and Product Overview 15

5.1 Ablynx NV Company Overview 15

5.1.1 Ablynx NV Pipeline Products & Ongoing Clinical Trials Overview 15

5.2 Aeon Research & Technology Company Overview 16

5.2.1 Aeon Research & Technology Pipeline Products & Ongoing Clinical Trials Overview 16

5.3 AFT Pharmaceuticals Ltd Company Overview 17

5.3.1 AFT Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview 17

5.4 Aura Medical Company Overview 20

5.4.1 Aura Medical Pipeline Products & Ongoing Clinical Trials Overview 20

5.5 Baby's Breath Ltd. Company Overview 21

5.5.1 Baby's Breath Ltd. Pipeline Products & Ongoing Clinical Trials Overview 21

5.6 Creare LLC Company Overview 22

5.6.1 Creare LLC Pipeline Products & Ongoing Clinical Trials Overview 22

5.7 DesignWise Medical Inc (Inactive) Company Overview 23

5.7.1 DesignWise Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 23

5.8 Marquette University Company Overview 24

5.8.1 Marquette University Pipeline Products & Ongoing Clinical Trials Overview 24

5.9 Parion Sciences Inc Company Overview 25

5.9.1 Parion Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 25

5.10 SolAeroMed Inc Company Overview 26

5.10.1 SolAeroMed Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.11 Stirling Pharma Inc Company Overview 27

5.11.1 Stirling Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview 27

5.12 University of California San Diego Company Overview 28

5.12.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 28

5.13 University of Texas Medical Branch at Galveston Company Overview 29

5.13.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 29

5.14 Verona Pharma Plc Company Overview 30

5.14.1 Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview 30

5.15 Vincent Medical Holdings Ltd Company Overview 31

5.15.1 Vincent Medical Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

6 Nebulizers- Recent Developments 32

6.1 Jul 16, 2018: Vectura Appoints Paul Fry as Chief Financial Officer and Executive Director 32

6.2 Jun 22, 2018: Owens & Minor Names Timothy P. Connolly as EVP, Operations & Supply Chain-Global Solutions 32

6.3 Jun 19, 2018: Cardinal Health Foundation Awards Over $3 Million to More Than 70 Nonprofit Organizations to Fight the Opioid Epidemic across Appalachia 33

6.4 Jun 04, 2018: Owens & Minor Appoints Interim Chief Financial Officer, as well as a Chief Accounting Officer 35

6.5 Jun 01, 2018: Vectura Group Appoints Anne Whitaker As Non-Executive Director 36

6.6 May 31, 2018: Copley Scientific releases new accessories for testing nebulisers with facemasks 36

6.7 May 29, 2018: Savara Provides Update on Case Reports of Inhaled Granulocyte-Macrophage Colony Stimulating Factor for the Treatment of Nontuberculous Mycobacteria Infection 36

6.8 May 24, 2018: OMRON Healthcare invests R$ 60 million to build a new plant in Jundia 37

6.9 May 14, 2018: Henry Ford Neurosurgeon and Epilepsy Expert Named President of National Pain Management Advocacy Group 38

6.10 May 11, 2018: Teleflex: Reaffirms 2018 Guidance and Provides 3-Year Financial Goals and Objectives 38

6.11 May 03, 2018: Cardinal Health Announces Third-quarter Results for Fiscal Year 2018 39

6.12 May 03, 2018: Teleflex Reports First Quarter 2018 Results 40

6.13 Apr 25, 2018: Boehringer Ingelheim has a very successful 2017 financial year 43

6.14 Apr 20, 2018: Vectura Announces Senior Management Change 44

6.15 Apr 20, 2018: Vectura Group: Directorate Change - Chief Financial Officer 44

7 Appendix 45

7.1 Methodology 45

7.2 About 48

7.3 Contact Us 48

7.4 Disclaimer 48